Post
Where do anti-tumor necrosis factor like cytokine agents go now?
In the past few months, significant interest within the inflammatory bowel disease (IBD) space has been directed towards the therapeutic …
Pharma’s engagement with healthcare providers has slipped in recent years
In recent years there has been a downward trend in health care provider (HCP) contact in the pharmaceutical industry with …
Amgen and MSD-backed start-up wins $10m for drug and device development
Culmination Bio has secured $10m in investment from the Merck Global Health Innovation Fund (venture capital arm of MSD) and …
CTO Europe 2023: EU’s IVD guidelines continue affecting early clinical work
The implementation of the In Vitro Diagnostic Medical Devices Regulation (IVDR) by the European Union (EU) continues to be a …
Waning focus on abuse potential may negatively affect pipeline non-stimulants for ADHD
The use of stimulants for attention deficit hyperactivity disorder (ADHD) treatment is increasing. Despite this, three out of the four …
CTO Europe 2023: EU’s IVD guidelines continue affecting early clinical work
The implementation of the In Vitro Diagnostic Medical Devices Regulation (IVDR) by the European Union (EU) continues to be a …
Waning focus on abuse potential may negatively affect pipeline non-stimulants for ADHD
The use of stimulants for attention deficit hyperactivity disorder (ADHD) treatment is increasing. Despite this, three out of the four …
Generation bio cuts 40% of staff in blow for non-viral gene therapy sector
US-based Generation Bio is cutting its workforce by 40%, becoming the latest company to announce lay-offs to save money this …
Cyclin Dependent Kinase 4 drugs in development, 2023
The Cyclin Dependent Kinase 4 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 4 targeted …
MSD reinforces Amazon partnership for faster AI-led drug discovery and development
Merck & Co (MSD) is continuing its multi-year cloud migration to Amazon’s cloud computing subsidiary Amazon Web Services (AWS), as …
CTO Europe 2023: Fostering diverse oncology trials remains a challenge
Lacking diversity in clinical trials remains a challenge as 73% of global study participants are white, based on data presented …
Placenta Growth Factor drugs in development, 2023
The Placenta Growth Factor pipeline drugs market research report outlays comprehensive information on the Placenta Growth Factor targeted therapeutics, complete …
Myc Proto Oncogene Protein drugs in development, 2023
The Myc Proto Oncogene Protein pipeline drugs market research report outlays comprehensive information on the Myc Proto Oncogene Protein targeted …
Nuclear Factor Erythroid 2 Related Factor 2 drugs in development, 2023
The Nuclear Factor Erythroid 2 Related Factor 2 pipeline drugs market research report outlays comprehensive information on the Nuclear Factor …
Bromodomain Containing Protein 4 drugs in development, 2023
The Bromodomain Containing Protein 4 pipeline drugs market research report outlays comprehensive information on the Bromodomain Containing Protein 4 targeted …